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Background: MicroRNAs are very small non-coding RNAs that interact with microRNA recognition elements (MREs)
on their target messenger RNAs. Varying the concentration of a given microRNA may influence the expression of
many target proteins. Yet, the expression of a specific target protein can be fine-tuned by alternative cleavage and
polyadenylation to the corresponding mRNA.
Results: This study showed that alternative splicing of mRNA is a fine-tuning mechanism in the cellular regulatory
network. The splicing-regulated MREs are often highly repressive MREs. This phenomenon was observed not only in
the hsa-miR-148a-regulated DNMT3B gene, but also in many target genes regulated by hsa-miR-124, hsa-miR-1, and
hsa-miR-181a. When a gene contains multiple MREs in transcripts, such as the VEGF gene, the splicing-regulated
MREs are again the highly repressive MREs. Approximately one-third of the analysable human MREs in MiRTarBase
and TarBase can potentially perform the splicing-regulated fine-tuning. Interestingly, the high (+30%) repression
ratios observed in most of these splicing-regulated MREs indicate associations with functions. For example, the
MRE-free transcripts of many oncogenes, such as N-RAS and others may escape microRNA-mediated suppression in
cancer tissues.
Conclusions: This fine-tuning mechanism revealed associations with highly repressive MRE. Since high-repression
MREs are involved in many important biological phenomena, the described association implies that splicing-
regulated MREs are functional. A possible application of this observed association is in distinguishing functionally
relevant MREs from predicted MREs.
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MicroRNAs, which are very short non-coding RNAs of
21–23 nucleotides in length, play an important role in
the regulation of gene expression, disease progression
[1], development [2,3], differentiation [4] and cancer [5].
This regulatory process is mainly mediated by targeting
microRNA recognition elements (MREs) in the 3′ un-
translated region (3′UTR) [6] or the coding region [7,8]
of one or more messenger RNAs (mRNAs). As a result,* Correspondence: yang@ym.edu.tw
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reproduction in any medium, provided the oreither the targeted messenger RNAs are cleaved or the
translation of transcripts is repressed [9].
Legendre et al. [10] hypothesized that some of the
shorter MRE-free transcripts may escape from microRNA-
mediated inhibition and further observed that alterna-
tive cleavage and polyadenylation (APA) reduces the
amount of MRE-containing isoforms in the correspond-
ing microRNA-expressed tissue. This finding is consistent
with the observation that approximately two-thirds of the
MRE-containing genes have isoforms in the 3′-UTRs [11].
This hypothesis is also supported by findings that activa-
tion of primary murine CD4+ T lymphocytes is associated
with an increased number of isoforms that lack MREs
[12]. Restated, these MRE-free isoforms have escaped
microRNA-mediated inhibition. Furthermore, in cancer
cells, oncogene activation is often accompanied by APA of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Method of identifying splicing-regulated MREs in a
given tissue. Step (I) is describing the data source used to derive
information about alternative splicing events of mRNA, tissue and
histology, and MRE. Step (II) is schematically depicting the above
three data types. Step (III) is integrating these three types of
information and specifies the EST configuration (see “Methods” for
detailed description). Step (IV) is establishing the two-way
contingency Table used for further analysis. Step (V) is performing a
statistical test to identify splicing-related MREs that have increased in
a given tissue.
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pressive elements [13]. The above reports reveal not only
that APA is a regulatory mechanism of microRNA-
mediated inhibition of protein expression, but also that a
functional MRE may reside in 3′-UTR. Yet not all func-
tional MREs are present in the 3′-UTR [14]. Whether this
inhibition can also be regulated by another mechanism is
yet to be explored.
In human multi-exon genes, 50% ~ 95% of primary tran-
scripts generate isoforms by alternative splicing (AS) or by
APA [15-19]. These events greatly increase the functional
complexity of the human genome. Some isoforms appar-
ently have active roles in various cell types or tissues
[20,21]. Therefore, although alternative splicing is an ef-
fective mechanism for generating isoforms, the isoforms
may lack functional elements in either the coding or non-
coding regions of a primary transcript. A recent systemic
study of the Arabidopsis thaliana plant in Yang et al. [22]
found a significantly higher frequency of alternative spli-
cing in MREs compared to other regions. However, the re-
lationship between microRNA-mediated inhibition and
alternative splicing has not been systematically studied in
humans. Moreover, no studies have investigated whether
splicing-regulated MRE is highly repressive or functional.
Therefore, this study analyzed not only the relationship
between alternative splicing and microRNA-mediated
protein inhibition, but also the role of splicing-regulated
MREs in protein repression.
Results
Discovering tissues enriched with specific isoforms
derived by alternative splicing
Expressed sequence tag (EST) sequences have proven
useful as a reference for identifying alternative splicing
in mRNA [23,24]. When sufficient EST sequences are
available, the number of EST sequences is approximately
proportional to the level of gene expression [25]. There-
fore, Legendre et al. [10] used the number of EST
sequences to determine the differential expression of
isoforms contained in EST libraries. They further used
this method to show that isoforms may or may not con-
tain conserved regulatory motifs. Since many microRNA
recognition elements (MREs) reveal evolutionary conser-
vation [26], MRE-containing or MRE-free transcripts
should be detected by a similar approach.
Even all EST sequences used in this study were
obtained from non-normalized cDNA libraries, the EST
approach suffers from several limitations. For example,
not observing an EST sequence does not mean that a
gene is not expressed. Thus, all the genes analyzed
herein have at least 10 EST sequences. Furthermore, the
3′end of a messenger RNA usually has more EST se-
quences, so the probabilities obtained by Fisher exact
test [10] tended to be underestimated. This bias favoursthe argument made herein concerning the observation
of a differential expression of the counts of an isoform
between a given tissue and all the other tissues. There-
fore, multiple libraries and additional EST sequences are
needed for further discovery of significant MREs. From
this point of view, the single cell RNA sequencing ap-
proach [27] will be better than pooling the information
from different libraries. However, the depth of the public
RNA sequencing data is not high enough to do a sys-
tematic survey.
Figure 1 shows the example of an MRE present in seven
EST sequences but absent from three other EST sequences
in brain tissue. However, MRE is present in one EST se-
quences but absent from six other EST sequences in “all
other tissues” (colon, lung, and liver in this example). The
two EST sequences from the liver library are excluded since
they do not include the entire MRE region. All the afore-
mentioned numbers can be summarized in a two-by-two
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exact test, (Additional file 1: Table S1-1A).
The DNA methyltransferase 3b (DNMT3B) gene is
known to contain two putative MREs that are targeted by
the human microRNA hsa-miR-148a [7]. The location of
these two MRE sites was found in the coding regions by
aligning the reported MRE sequences with the reference
sequence of UniGene cluster Hs.713611 (Figure 2A).
Transcript DNMT3B3 contains only MRE site#2 (nucleo-
tide 1775–1797), but transcript DNMT3B1 contains
both MRE site#1 (nucleotide 2739–2767) and MRE site#2
(Figure 2A and Additional file 1: Figure S1-1). The site#1
MRE-free transcript (i.e. DNMT3B3) encodes a protein,
which has an in-frame deletion of about 83 amino acids
compared to the protein encoded by the site#1 MRE-
containing transcript (i.e. DNMT3B1). This deletion
removes the catalytic site of the methylase activity [28],
but it is not clear whether this shorter protein still have
the DNA 5-hydroxymethylcytosine dehydroxymethylase
activity [29].
The site#1 MRE-free DNMT3B3 transcript may escape
translational suppression by hsa-miR-148a, which is
expressed in many tissues, such as human embryonicFigure 2 Splicing-regulated MRE of DNMT3B gene. (A) Putative
hsa-miR-148 recognition sites in human DNMT3B coding region. Symbol
“▲” indicated MRE#1 while “△” indicated MRE#2. (B) Relative numbers of
MRE-containing and MRE-free transcripts from various MRE sites. (C) The
negative log10 transformed P values in selected tissues. Asterisk represents
statistical significance at P < 0.05, determined by Fisher exact test (left or
right side).stem cell [30], brain [31], cervix [32] and other tissues
[33]. Therefore, the different isoforms transcribed from
the DNMT3B gene might be a good starting point to ex-
plore the effect of alternative splicing on microRNA-
mediated suppression of protein expression.
Since DNMT3B is abundantly expressed in ES cells
and early embryos [34], alternative splicing effects can
be studied in embryonic tissue. To test whether the
highly repressive (repressive ratio ~50%) site#1 MRE [7]
is regulated by an alternative splicing event, gene expres-
sion was compared between site#1 MRE-containing
isoforms and site#1 MRE-free isoforms. Figure 2B shows
that, in embryonic tissue, site#1 MRE-containing (i.e.
DNMT3B1) isoforms are represented by more EST se-
quences compared to site#1 MRE-free isoforms (i.e.
DNMT3B3). Left-sided Fisher exact test (see “Methods”
for details) showed that the expression in embryonic tis-
sue significantly differed from those of all other tissues
(P = 0.0019). In other words, embryonic tissue expressed
a higher proportion of site#1 MRE-containing transcript
than that in all other tissues and might be more respon-
sive to the hsa-miR-148a-mediated protein repression
than that in all other tissues.
In contrast, site#2 MRE-free and site#2 MRE-containing
isoforms showed no significant differences between “em-
bryonic tissue” and “all other tissues” based on Fisher exact
test. Since the proportion of site#2 MRE-containing tran-
scripts was not significantly changed by alternative splicing
event, site#2 MRE was not expected to have a great differ-
ence in hsa-miR-148a-mediated protein repression.
Splicing-regulated site#1 MRE in DNMT3B transcripts is
highly repressive
To examine whether alternative splicing may regulate
miRNA-mediated protein repression in other tissues,
Fisher exact tests were performed in several tissues with
sufficient EST sequences. Figure 2C and Additional file 1:
Table S1-1B show that the statistically significant P-value
obtained by right-side Fisher exact test for brain tissue in-
dicated preferential expression of site#1 MRE-free tran-
script (i.e. DNMT3B3) in the brain. This result in brain
tissue was opposite to that in embryonic tissue. The obser-
vations based on EST approach were also supported by
the single cell RNA sequencing data [27]. For example,
the tag counts of those site#1 MRE-containing and site#1
MRE-free isoforms in human embryonic and brain tissues
were consistent with the observations by EST approach
qualitatively (Additional file 2). Accordingly, alternative
splicing is apparently able to regulate protein expression
in different tissues.
According to TarBase [35] and miRTarBase [36], hsa-
miR-148a has one and seven experimentally verified tar-
get messenger RNAs, respectively. In the DNMT3B3
gene, site#1 MRE-free transcript may escape repression
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targeted genes in the brain. Restated, by changing the
properties of a transcript rather than by changing the
concentration of a given microRNA, alternative splicing
may be an additional regulatory mechanism in protein
expression. This additional regulatory mechanism may
be useful in fine-tuning the complex gene expression
circuit.
The biological importance of microRNA-mediated
regulation is typically associated with a highly repressive
MRE. Comparisons of microRNA–mediated repression
in different mRNA isoforms has been successfully used
to associate MRE sites with functions in many studies,
such as the prediction of target mRNAs [37-41], the in-
fluence of intron retention on human mRNA [42], cellu-
lar proliferation and differentiation [12,43], and cancer
[44]. The effect of fine-tuning at the splicing level would
be negligible if the associated MREs are not highly repres-
sive. Therefore, we predicted that MREs that regulated by
splicing are also highly repressive. The DNMT3B analysis
in this study showed that only site#1 MRE is highly com-
plementary to hsa-miR-148a and is highly repressive (re-
pressive ratio ~50%) of protein expression [7]. However,
site#2 MRE has little no effect (repressive ratio ~10%),
which is consistent not only with the above argument, but
also with selection pressure in the evolutionary process.
That is, if a highly repressive MRE for fine-tuning the
microRNA-mediated protein suppression provided a se-
lection advantage, the highly repressive MRE would be
preserved in evolution. Therefore, the alternative splicing-
modulated protein repression is likely to be associated
with highly repressive MRE. In contrast, a weak repressive
MRE would confer a smaller selection advantage because
of the limited effect of splicing-mediated protein suppres-
sion by microRNA. Thus, the weak repressive MRE might
no longer be associated with the splicing-level regulation
in the evolutionary process.
Proteomic evidence that highly repressive MREs are
generally associated with alternative splicing events
Until now, the association between alternative splicing
and highly repressive MRE has been supported only by a
single microRNA and a single target messenger RNA.
Whether this evidence is applicable to other target mes-
senger RNAs is unclear. Furthermore, gene expression is
typically, but not always, proportional to protein expres-
sion [45]. Therefore, further studies are needed to deter-
mine whether alternative splicing-regulated MREs are
generally highly repressive of protein expression.
The global impact of a microRNA, such as miR-124,
on the protein expression in the HeLa cell has been
measured by stable isotopic labelling with amino acids
in cell culture (SILAC) analysis [46], a mass spectrom-
etry technique for using non-radioactive isotopiclabelling to detect differences in protein abundance
among samples. The SILAC results can also be used to
calculate protein expression-based repression. The ana-
lysis herein identified 1,544 differentially expressed pro-
teins whose expression resulted from expression of hsa-
miR-124 in HeLa cells. However, only 1,486 have sym-
bols in UniGene#230 (and are referred to as the “Proteo-
mics” fraction, Additional file 1: Table S1-2A).
Approximately half of these 1,486 proteins were re-
pressed and, of these, approximately half were activated
(Additional file 1: Table S1-2B and Text S1-1). These
1,486 proteins identified by proteomic analysis of HeLa
cells were used as the starting point in a global analysis.
These proteins include the direct targets of hsa-miR-124
and the downstream proteins of the hsa-miR-124-regulated
target genes [47]. Target proteins were distinguished
from downstream proteins by labelling the putative tar-
get messenger RNA as “seed”, which is a 7-nucleotide
feature typically found at the 3′-end of an MRE and
complementary to the 5′-end of a microRNA. The
presence of a “seed” is thus considered evidence of a
candidate MRE. Of these 1,486 proteins, the presence
of the seed” region on the transcript indicated that only
408 proteins are directly regulated by hsa-miR-124
(Proteomics∩Seed(ALL), red line in Figure 3). Since the
repression is too weak for depiction by histogram, the
variation in repression in different states was compared
by plotting a cumulative curve [12,19,46,48] of the per-
centage of proteins in the given range of repression ra-
tios. Figure 3 plots the cumulative curves based on the
percentage of counted genes according to the full-
length “seed” matches presented in Additional file 1:
Table S1-2B and the results of the paired statistical ana-
lysis in Additional file 1: Table S1-2C.
The remaining 1,078 seed-free detected proteins were
labelled “Proteomics∩Seed(X)” (blue line in Figure 3).
The red line showed a significant left shift relative to the
blue line (P < 0.001, in a Kolmogorov-Smirnov (KS) test
with two independent samples, Additional file 1: Table
S1-2C), indicating that repression was greater in the
seed-annotated proteins compared to other differentially
expressed proteins. However, the presence of a seed usu-
ally, but not always correlates with an MRE [37]. There-
fore, these “seed”-containing transcripts were further
evaluated by the miRSVR algorithm [49] to predict the po-
tential target of hsa-miR-124. These miRSVR-predicted
MREs are considered putative MREs. In Figure 3, the cu-
mulative curve of (Proteomics∩Seed(ALL)∩miRSVR) indi-
cated by the purple line is significantly shifted to the left
of the blue curve (P < 0.001, KS test, Additional file 1:
Table S1-2C), indicating that the target prediction method
is better than seed-free detected target messenger RNA.
Alternative splicing was then analyzed in target genes
(Proteomics∩Seed(ALL)∩miRSVR) encoding differentially
Figure 3 Cumulative curves representing the cumulate fraction of target proteins that were repressed or activated after transfection
of hsa-miR-124 to HeLa cells. Variation in different states was compared by plotting a cumulative curve [12,19,46,48] of the percentage of
proteins in the given range of repression ratios. The x-axis represents the protein output as the percentage change in the expression ratio of
HeLa cells. The y-axis represents the cumulative percentage. The text defines the terms proteomics, seed (X), seed (ALL), miRSVR, and AS. All data
other than AS information are taken from Baek, et al. [46]. A table contained statistic results was also included in the lower right corner.
Wu et al. BMC Genomics 2013, 14:438 Page 5 of 12
http://www.biomedcentral.com/1471-2164/14/438expressed proteins. Additional file 1: Table S1-2 presents
those proteins that were potentially controlled at the
splicing level (Proteomics∩Seed(ALL)∩miRSVR∩AS). The
cumulative curve of these splicing-regulated target pro-
teins (green line in Figure 3) exhibited the highest repres-
sion, because the green curve shifted further to the left of
the blue curve (seed-free target proteins) (P < 0.001, KS
test, Additional file 1: Table S1-2C).
In addition to hsa-miR-124, the SILAC analysis [46] was
also used to examine the on the global impact of hsa-miR-1
and hsa-miR-181a on protein expression in HeLa cell. This
global trend has also been reported in studies of hsa-miR-1
and hsa-miR-181a (Additional file 3), which are consistent
with the previous observation on hsa-miR-124. In sum-
mary, the ratio of repressive proteins was apparently higher
in the alternative splicing-regulated target proteins com-
pared to the remaining differentially expressed proteins.
This global analysis of multiple target proteins of a single
microRNA supports the association between alternative
splicing and highly repressive MRE.
Splicing-regulated MREs are highly repressive in
transcripts that contain multiple MREs
The DNMT3B gene is a good example of the highly re-
pressive splicing-regulated MRE of hsa-miR-148a. The
repressive effect is also observed in the target genes of
hsa-miR-124 at the protein level. However, many genes
are targeted by multiple miRNAs in the cells. For ex-
ample, approximately 30 putative miRNAs regulate thevascular endothelial growth factor (VEGF) gene [50]. To
see the repressive effect and for a fair comparison, differ-
ent MREs but with at least 90% overlap were grouped
into a single “MRE region”. After alignment of the
reported MRE regions with UniGene cluster Hs.73793,
the splicing-regulated MREs were identified as described
above in relation to Figure 1. Thirteen putative splicing-
regulated MRE regions were identified (Figure 4) by
comparing the locations of MRE regions with splicing
sites. The repressive ratio data for these sites were col-
lected in hypoxia-induced CNE cells (a nasopharyngeal
carcinoma cell line) by introducing synthetic putative
VEGF-regulative microRNA duplexes to this cell line
[50] (Figure 4, bottom panel). Of these 13 putative
splicing-regulated MRE regions, nine (approximately
70%) were considered highly repressive MRE regions (re-
pressive ratios of +30%): regions 1, 2, 3, 4, 5, 7, 9, 11 and
12 (Table 1, Figure 4, bottom panel).
The cancer (top) and normal (middle) panels in
Figure 4 plot the negative log10 transformed P values of
all MREs. Four MRE regions showed significant splicing
regulation (P < 0.05) in at least one cancer tissue. Two
MRE regions appeared to be splicing-regulated in at
least one normal tissue. These splicing-regulated MREs
were marked with red stars in the two-tail test panels in
Figure 4. The normal and cancerous tissues contained
five splicing-regulated MRE regions. All five of the
splicing-regulated MRE regions (according to Fisher
exact test) are also highly repressive MRE regions even
Figure 4 Comparison of splicing-regulated MRE regions and highly repressive MREs in VEGF gene. For the alternative splicing analysis of
the 13 MRE regions, the top, middle, and bottom panels present the results obtained for cancer tissues, the results obtained for normal tissues,
and the repressive ratios reported in the literature, respectively. The negative log10-transformed P-values for the 13 MRE regions (numbered in
the bottom panel) are presented in blue, red, and green and correspond to the left-side, right-side, and two-tail Fisher exact tests, respectively.
The red star indicates statistical significance at P < 0.05, determined by Fisher exact test. Highly repressive MREs with repression ratios above 30%
are found in MRE regions 1, 2, 3, 4, 5, 7, 9, 11 and 12. Putative hsa-miR-148 recognition sites in human DNMT3B coding region. Dotted red line
indicates significance region (P < 0.05).
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alternative splicing. This implies that analysis of splicing
regulation may reveal highly repressive or “true” MREs.
Approximately one-third of experimentally confirmed
MREs are associated with alternative splicing events
Table 1 shows that, in many miRNAs that target VEGF
messenger RNA, splicing-regulated MREs were associ-
ated with highly repressive MREs. Despite the import-
ance of this observation, this phenomenon is not
biologically significant if splicing-regulated MREs are
special cases. Therefore, alternative splicing analysis was
repeated in experimentally supported human targets
based on the reporter assay results [35]. Random MREs
were also analyzed to evaluate background effects. Not-
ably, the true MRE was positively validated by the algo-
rithm, the false MRE was negatively validated by the
algorithm [35], and the random MRE was simply ran-
domly selected from reference sequences. If our observa-
tion of DNMT3B is widely applicable, then the opportunityto observed splicing-regulated MRE would be greater for
the experimentally verified MREs than for the false or ran-
dom MREs.
The sequences of translationally repressed human
MREs and false MREs were retrieved from both
miRTarBase release 2.5 [36] and TarBase v.4.0 [35] and
aligned to the corresponding reference sequences in
UniGene database (see Methods). Only MREs with at least
ten EST sequences were included in further analyses. The
analysis included 256 unique MRE sites obtained from
miRTarBase and 72 unique MRE sites and 14 unique false
sites obtained from TarBase. From the 3′UTR and full-
length sequences, 170,000 and 431,500 distinct random
MREs were generated, respectively.
The number of unique MRE sites was determined by ap-
plying the following two rules. First, an MRE targeted by
multiple microRNAs (e.g., hsa-miR-20a and hsa-miR-17
both targeting the same MRE in the E2F1 gene) was
considered a single site. Second, significant tissue types
(Additional file 1: Figure S1-2) identified in the alternative
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nificant tissue types (Additional file 1: Figure S1-2) identi-
fied in the alternative splicing analysis of a given MRE
were defined as splicing-regulated. Alternative splicing in
at least one tissue was identified in 95 out of 256 (37.1%)
MRE sites in miRTarBase and in 22 out of 72 (30.6%)
MRE sites in TarBase (Figure 5). These percentages were
2.2 and 2.6 times those of the false MRE sites in TarBase
and miRTarBase, respectively. The percentages of both
the true and false MRE sites significantly differed (average,
9.7%) from those of the random MRE sites selected from
3′ UTR or full-length sequence (P < 0.001, one-sample
Wilcoxon signed-rank test). A possible explanation for the
difference is that negative validation of the algorithm-
predicted MRE has been reported for only one or a few
tissues, which may significantly differ from other tissues in
the EST libraries. The percentage of significant randomly
selected MREs in this analysis (9.7%) also differed from
those in Additional file 1: Figure S1-2B (2.8%) because the
latter treated MREs as independent in different tissues.
The experimental results show that approximately
one-third of the true MREs were associated with AS
events. Additionally, reported repressive ratios exceeded
30% in almost all proteins in Figure 6. Restated, the as-
sociation between splicing-regulated MREs and highlyFigure 5 Comparison of predicted splicing-regulated MREs from true
fractions of splicing-regulated MREs contained in miRTarBase [36] and TarB
validation, and false MRE is the algorithm-predicted MRE with negative vali
splicing regulation predicted in MREs randomly selected from reference se
randomly selected MRE sets (100 random MREs/set), which were sampled f
P-value was computed by one-sample Wilcoxon signed-rank test.repressive MREs is again supported by other microRNAs
and their target messenger RNAs.
Discussion
This study showed that splicing-level regulation is a
fine-tuning mechanism in the expressions of specific
proteins. The fine-tuning process described above en-
ables regulation of a single protein in the presence of all
the other target proteins of a given microRNA. Briefly,
specific examples of this process were extended to all
analysable human targets in TarBase and miRTarBase.
The microRNA-mediated regulation is quite complex.
For example, a single microRNA may have multiple tar-
get genes, and a messenger RNA may be targeted by
multiple microRNAs. Alternative splicing enables inde-
pendent regulation of protein expression in a single
gene. An MRE-containing isoform can be co-regulated
with other target genes, but an MRE-free isoform may
escape regulation of the matching microRNA.
Additionally, splicing-regulated MREs established here
were highly repressive (repressive ratios +30%). This
highly repressive character may enhance the effective-
ness of alternative splicing. The fine-tuning process may
exert a positive selection pressure in evolution. This ef-
fect may explain why almost all observed splicing-, false, and randomly selected MREs. The left panel shows the
ase [35]. True MRE is the algorithm-predicted MRE with positive
dation defined from TarBase. The right panel shows a histogram of
quences. Data for random MREs were averages over 4,315 or 1,700
rom full-length (green) and 3′-UTR (red) sequences, respectively.
Figure 6 Predicted highly repressive MREs from TarBase v.4.0. $ Red bar indicate the level of significance; * Listed numbers were
experimental repression ratios obtained manually from full-text cited by TarBase.
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genes require fine-tuning. Therefore, highly repressive
MREs may not necessarily be regulated by alternative
splicing. For example, the highly repressive (repressive
ratio 75%) hsa-miR-137-specific MRE in the CDC42
gene [22] is not associated with alternative splicing (data
not shown).
The discussed fine-tuning mechanism also suggests a
means for cancer cells to escape regulation in a normal
cell. As presented in Figure 6, enrichment of splicing-
regulated MRE regions was significantly increased in can-
cer cells according to right-sided Fisher exact test. This
right-side significance indicates an increased amount of an
MRE-free transcript in cancer cells. Restated, genes such
as CSDE1, ERBB2, ERBB3, GJA1, N-RAS, SLC16A,
SMAD1, TMSB4X, TMSL3, TTK, and ZNF513 were up-
regulated in cancer cells. This result is consistent with the
notion that a loss of repressive elements located in 3′ un-
translated regions (3′UTRs) by alternative cleavage and
polyadenylation (APA) was associated with oncogene acti-
vation [13] and cellular activation [12]. Thus, the above
association is not only a common phenomenon, it also
has important biological implications.
Regarding applications, identifying functional MREs is
critical to determining the biological function of
microRNAs. However, measuring the repressive ratio at
an MRE site is laborious. Although the prediction algo-
rithm considered many factors, the false positive rate
was unacceptably high [3,50,51]. Therefore, predictingthe functional MREs of a given microRNA remains chal-
lenging [52,53]. Our experimental results suggest that al-
ternative splicing can also be used to filter and identify
functional MRE sites from a list of putative sites pre-
dicted by microRNA target identification algorithms.
The false-negative rate of the suggested method of iden-
tifying novel targets of miRNAs is high since approxi-
mately two-thirds of the true MREs were unassociated
with AS events. Although this method is not compre-
hensive, the false positive rate is low. More importantly,
most of these splicing-regulated MREs are highly repres-
sive MREs, which have functional implications.
Conclusions
In conclusion, the discovery of splicing-regulated MREs
reveals an important fine-tuning mechanism in complex
microRNA-mediated regulation. This phenomenon is
widely observed in human cells and is accompanied by
the strong repression of protein expression. This novel
and biologically significant observation is useful for iden-
tifying MREs, which may have important biological
functions.
Methods
EST data source and prediction of spliced sites
Publically available Expressed Sequence Tag (EST) se-
quences were used to discover isoforms of messenger
RNA [24,54,55]. Alternatively spliced isoforms can be
identified by aligning EST sequences with reference
Wu et al. BMC Genomics 2013, 14:438 Page 10 of 12
http://www.biomedcentral.com/1471-2164/14/438messenger RNA sequences. Tissues that express a par-
ticular EST sequence can also be annotated with NCBI
information. The MRE-containing or MRE-free isoforms
can then be identified by comparing the locations of
functional MREs with alternative splicing (AS) sites. The
UniGene (Human, Build #230) database was used to dis-
cover the alternative splicing sites by aligning each EST
sequence with the reference sequence, which was the
longest high-quality sequence in the NCBI (file “Hs.seq.
uniq”). Alignment was performed in sim4 using the de-
fault parameters [56] as described by Huang, et al. [24].
The relationship between a putative splicing site and an
MRE site (see below for details) was determined by com-
paring the locations of the above two features.
Alignment of experimentally verified and predicted MREs
with the reference sequence
The known microRNA genes were obtained from miRBase
(version 17.0) [41] and the experimentally verified MREs
were downloaded or retrieved from TarBase (version 4.0)
[35] and miRTarBase (release 2.5) [36]. For each predicted
MRE, information obtained from microRNA.org (August,
2010 Release) [57] included potential binding sites identi-
fied by using the mirSVR [49] and miRanda [58] algorithms
for a given microRNA. The MRE positions were then iden-
tified by using the BLASTN algorithm [59] to match each
MRE with the reference sequences and then retaining only
those with perfect matches over their full length.
Configuration of EST sequence and Fisher exact test
As in step (III) of Figure 1, information about alternative
splicing, tissue, histology (normal vs. cancer), and MRE
were integrated. Tissue and histology information were
obtained from the EST library established by the Cancer
Genome Anatomy Project [60,61]. After the splicing and
MRE information were integrated, each EST sequence
had five possible configurations in relation to a specified
MRE sequence: (i) partial or no overlap with MRE; (ii)
absence of MRE in a putative exon; (iii) presence of
MRE in a putative intron; (iv) partial MRE at the exon-
intron junction, and (v) other. Each EST sequence was
assigned a configuration number in this step (e.g., see
the parenthesis after a given tissue name in step (III) of
Figure 1) and was classified accordingly. Each configur-
ation had a unique biological meaning. In configuration
(i), the EST sequence was unrelated to alternative spli-
cing. In configuration (ii), the EST sequence was in an
MRE-containing isoform. In configuration (iii), the EST
sequence was in an MRE-free isoform. In configuration
(iv), the isoform contained only a partial, and potentially
non-functional, MRE. Therefore, the isoform was classi-
fied as an MRE-free isoform.
The EST sequences were grouped according to whether
they were MRE-containing or MRE-free isoforms invarious tissues and histologies. In step (IV) (Figure 1), a
two-way contingency table was established to determine
whether the counts of MRE-free or MRE-containing
isoforms were over-represented in a given tissue, in rela-
tion to “all other tissues”. The statistical analyses were
limited to tissues with at least ten EST sequences. The P-
value was computed by Fisher exact test (Figure 1 and
Additional file 1: Table S1-1A) to identify non-random
associations between two categorical variables. The null
hypothesis was that, in the absence of natural selection,
the proportion of (MRE-free isoforms/MRE-containing
isoforms) in a given tissue is identical to that in all
other tissues. Therefore, the hypergeometric distribu-
tion was used to calculate the probabilities of the ob-
served data and all data sets with more extreme
deviations. When a given tissue showed enriched MRE-
containing isoforms, the left-side P-value was signifi-
cant in one-tailed Fisher exact test. In contrast, when a
given tissue showed increased MRE-free isoforms, the
right side P-value was significant in a one-tailed Fisher
exact test.Preparing random sequences for Wilcoxon signed-rank
test
To observe the background effect of the configuration in
Figure 1, 170,000 and 431,500 different MREs were ran-
domly generated from 3′UTR and full-length sequences,
respectively. The numbers of random MREs sufficed for
the purposes of this study since 2.8% of 100,000 random
MREs were putative splicing-regulated MREs (P < =0.05,
see red line in Additional file 1: Figure S1-2B indicating
accumulated probability of all MREs randomly selected
for statistical analysis). These reference sequences were
randomly selected from the UniGene database for use as
source sequences. The sequence source, the starting pos-
ition of a random sequence, and the length (18 ~ 22 nu-
cleotides) of a random sequence were all randomized.
Once the starting site had been determined, an MRE se-
quence was randomly generated from the source sequence
under the constraint of MRE length. Therefore, all se-
lected MREs were in the source sequences and were in-
cluded in the isoform enrichment analysis described
above. Since the amounts of splicing-regulated random
MREs were not normally distributed among these two sets
(Figure 5, right panel), one-sample Wilcoxon signed-rank
test was used to differentiate between true MREs and ran-
domly generated MREs.Additional files
Additional file 1: Supplementary texts, figures and Tables.
Additional file 2: Single-cell level mRNA-seq analysis of human
embryonic and brain tissue.
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